股票代码：600421 股票简称：*ST华嵘 公告编号：临 2025-048 湖北华嵘控股股份有限公司 股票交易异常波动暨风险提示公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 根据《上海证券交易所股票上市规则》有关规定，公司股票因第 9.3.2 条有关情形被实施*ST 的第二年只要出现第 9.3.7 条规定的任意情形就将触及财 务类退市。请投资者务必注意投资风险，谨慎投资。 ● 经公司自查，并向公司控股股东及其一致行动人、实际控制人发函核实， 截至本公告披露日，除已披露事项外，确认不存在应披露而未披露的重大事项或 重大信息。 ● 经公司自查，本公司及控股子公司生产经营正常，市场环境或行业政策 没有发生重大变化，不存在应披露而未披露的重大信息。 一、股票交易异常波动的具体情况 ● 据公司控股股东浙江恒顺投资有限公司（以下简称"浙江恒顺"）及其 一致行动人上海天纪投资有限公司（以下简称"上海天纪"）与收购人海南伯程 汇能科技中心（有限合伙）（以下简称"伯程汇能"或"海南伯程"）签署的《股 权转让协议》， ...

北京商报讯（记者 翟枫瑞）8月19日，装修建材板块午盘小幅增长，以14716.08点收盘，涨幅为 0.80%。在板块带动下，多只装修建材股午盘股价实现增长。康欣新材午盘以2.97元/股收盘，涨幅为 10.00%，领涨装修建材股。*ST松发午盘以56.46元/股收盘，涨幅为4.56%，涨幅位列装修建材股第二。 *ST四通午盘以6.65元/股收盘，涨幅为4.23%，涨幅位列装修建材股第三。除此之外，麒盛科技午盘以 14.37元/股收盘，跌幅为3.43%，领跌装修建材股。濮耐股份午盘以7.24元/股收盘，跌幅为2.69%，跌幅 位列装修建材股第二。好莱客午盘以11.31元/股收盘，跌幅为1.82%，跌幅位列装修建材股第三。 东吴证券发布建筑材料行业研报称，整体而言，地产链的斜率放缓但方向不变，地产链出清已近尾声， 供给格局大幅改善，25年需求平稳且企业增长预期较低，板块具备较高的胜率。以旧换新补贴推动下， 24年Q4家电消费加速，到25年3月家具消费明显加速，期待25年Q3家装也会迎来明显加速。 ...

股票代码：600421 股票简称：*ST华嵘 公告编号：临 2025-047 湖北华嵘控股股份有限公司 股票交易风险提示公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、生产经营情况 重要内容提示： 1 据公司控股股东浙江恒顺投资有限公司（以下简称"浙江恒顺"）及其一致 行动人上海天纪投资有限公司（以下简称"上海天纪"）与收购人海南伯程 汇能科技中心（有限合伙）（以下简称"伯程汇能"或"海南伯程"）签署 的《股权转让协议》，本次收购华嵘控股 25.01%的股份，伯程汇能需支付现 金对价 45,041.29 万元，截至目前，收购方伯程汇能的相关收购资金尚未准 备到位；同时按照《上市公司收购管理办法》的有关规定，收购方应当编制 《详式权益变动报告书》，聘请财务顾问并出具《财务顾问报告》。截至目 前，收购方伯程汇能的《详式权益变动报告书》尚未编制，且尚未聘请财务 顾问。本次收购能否完成存在重大不确定性，敬请投资者注意投资风险。 公司 2024 年度经审计的扣除非经常性损益后的净利润为负值，且扣除与主 营业务无关的业务收 ...

Core Viewpoint - The announcement highlights the ongoing acquisition process of Hubei Huaron Holdings Co., Ltd. by Hainan Bocheng Huineng Technology Center, which faces significant uncertainties regarding the completion of the transaction due to the lack of prepared funds and necessary documentation [2][8]. Group 1: Stock Trading Anomalies - The company's stock experienced a cumulative price deviation of 12% over three consecutive trading days from August 12 to August 14, 2025, indicating abnormal trading activity [4][11]. - The stock has been under a delisting risk warning since April 29, 2025, due to negative net profit and low operating revenue [3][11]. Group 2: Acquisition Details - Zhejiang Hengshun Investment Co., Ltd. and its acting party Shanghai Tianji Investment Co., Ltd. signed a share transfer agreement to sell 25.01% of Hubei Huaron's shares to Hainan Bocheng for a cash consideration of 450.4129 million yuan [2][8]. - As of the announcement date, the acquiring party has not prepared the necessary funds or completed the required detailed equity change report [2][8]. Group 3: Company Operations and Financial Health - The company reported a projected net loss of 4 million to 2.7 million yuan for the first half of 2025, with a net profit excluding non-recurring items expected to be between -4.2 million and -2.8 million yuan [3][11]. - A self-inspection confirmed that the company's operations are normal, and there have been no significant changes in the external business environment [5][10]. Group 4: Regulatory Compliance - The company is actively addressing the regulatory inquiries from the Shanghai Stock Exchange regarding the share transfer and control change, with a response expected by August 21, 2025 [17]. - The company has confirmed that there are no undisclosed significant matters or information that could impact its stock price [10][12].

股票代码：600421 股票简称：*ST华嵘 公告编号：临 2025-045 湖北华嵘控股股份有限公司 股票交易异常波动暨风险提示公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 据公司控股股东浙江恒顺投资有限公司（以下简称"浙江恒顺"）及其 一致行动人上海天纪投资有限公司（以下简称"上海天纪"）与收购人海南伯程 汇能科技中心（有限合伙）（以下简称"伯程汇能"或"海南伯程"）签署的《股 权转让协议》，本次收购华嵘控股 25.01%的股份，伯程汇能需支付现金对价 45,041.29 万元，截至目前，收购方伯程汇能的相关收购资金尚未准备到位；同 时按照《上市公司收购管理办法》的有关规定，收购方应当编制《详式权益变动 报告书》，聘请财务顾问并出具《财务顾问报告》。截至目前，收购方伯程汇能 的《详式权益变动报告书》尚未编制，且尚未聘请财务顾问。本次收购能否完成， 后续收购程序存在重大不确定性，敬请投资者注意投资风险。 ● 湖北华嵘控股股份有限公司（以下简称"公司"）股票于 2025 年 8 月 12 日、8 月 ...

股票代码：600421 股票简称：*ST华嵘 公告编号：临 2025-046 湖北华嵘控股股份有限公司 公司对《监管工作函》相关事项高度重视，积极督促收购方海南伯程汇能科 技中心（有限合伙）及相关方对《监管工作函》有关问题进行核查并回复。按照 《上市公司收购管理办法》的有关规定，海南伯程汇能科技中心（有限合伙）作 为收购方应当编制《详式权益变动报告书》，聘请财务顾问并出具《财务顾问报 告》。截至目前，海南伯程汇能科技中心（有限合伙）聘请财务顾问的工作尚在 1 进行中，相关核查工作需待财务顾问机构聘请确定后进行。公司将延期回复《监 管工作函》，公司预计在 2025 年 8 月 21 日前完成《监管工作函》回复并对外披 露。 公司将积极督促相关方尽快完成《监管工作函》的回复工作并及时履行信息 披露义务。公司指定信息披露媒体和网站为《证券时报》《中国证券报》及上海 证券交易所网站 www.sse.com.cn），有关信息以公司在上述指定媒体和网站披露 的信息为准，敬请广大投资者理性投资，注意投资风险。 特此公告。 湖北华嵘控股股份有限公司董事会 2025 年 8 月 15 日 关于延期回复上海证券交易所《监管工作函 ...

Core Viewpoint - Hubei Huaron Holdings Co., Ltd. experienced a significant stock price fluctuation, with a cumulative increase of 12% over three consecutive trading days, indicating abnormal volatility [1] Group 1: Stock Performance - The stock price of Hubei Huaron Holdings has shown a cumulative increase of 12% over three trading days, which is classified as abnormal volatility [1] Group 2: Share Transfer Agreement - The controlling shareholder and its concerted parties signed a share transfer agreement with Bocheng Huineng to transfer 25.01% of shares for a consideration of 450.4129 million yuan [1] - The acquisition funds have not yet been secured, leading to uncertainties regarding the transaction [1] - The detailed equity change report has not been prepared, and no financial advisor has been appointed, further adding to the uncertainty of the acquisition [1] Group 3: Financial Performance and Risks - The company reported a negative net profit excluding non-recurring items for 2024, with expectations of continued losses in the first half of 2025 [1] - The stock has been subjected to delisting risk warnings, and if certain conditions are met next year, it may face financial delisting [1] - The company has advised investors to be cautious and to invest rationally [1]

Core Viewpoint - The announcement highlights the acquisition of 25.01% of Hubei Huaron Holdings Co., Ltd. by Hainan Bocheng Huineng Technology Center, with a cash consideration of approximately 450.41 million yuan. However, the acquisition faces significant uncertainties as the required funds have not yet been secured, and necessary reports have not been prepared [2][7]. Group 1: Acquisition Details - The acquisition involves Zhejiang Hengshun Investment Co., Ltd. and its action-in-concert party Shanghai Tianji Investment Co., Ltd. transferring shares to Hainan Bocheng Huineng, with a total of 48,904,775 shares being transferred [6][18]. - The cash consideration for the acquisition is set at 9.21 yuan per share, totaling approximately 450.41 million yuan [20]. - The acquisition is subject to regulatory approvals and the completion of necessary documentation, which has not yet been fulfilled [24]. Group 2: Financial Performance and Risks - The company reported a negative net profit for the fiscal year 2024, with revenues from core business activities falling below 300 million yuan, triggering a risk warning for delisting [3][8]. - The projected net profit for the first half of 2025 is expected to be between -4 million and -2.7 million yuan, indicating ongoing financial difficulties [3][8]. - The stock has experienced significant price fluctuations, with trading halts occurring on multiple days, raising concerns about market volatility [5][6]. Group 3: Operational Status - The company's production and operational activities are reported to be normal, with no significant changes in the main business operations [4]. - There are no undisclosed major events that could affect the stock price, indicating a stable operational environment despite financial challenges [4].

Core Points - The Shanghai Composite Index closed at 3666.44 points, slightly down by 0.46%, with a total trading volume of 23062.83 billion yuan [1] - A total of 11 A-shares have surpassed their annual line, with notable stocks showing significant deviation rates, including *ST Xinyuan at 4.65%, *ST Huarong at 4.40%, and Meihua Medical at 2.93% [1] Summary by Category Market Performance - The Shanghai Composite Index is above the annual line, indicating a positive market sentiment despite a minor decline [1] - The total trading volume for A-shares reached 23062.83 billion yuan, reflecting active market participation [1] Stocks Surpassing Annual Line - The stocks with the highest deviation rates include: - *ST Xinyuan: 11.82% increase, 19.23% turnover rate, annual line at 6.06 yuan, latest price at 6.34 yuan, deviation rate of 4.65% [1] - *ST Huarong: 4.94% increase, 0.45% turnover rate, annual line at 7.12 yuan, latest price at 7.43 yuan, deviation rate of 4.40% [1] - Meihua Medical: 3.05% increase, 14.95% turnover rate, annual line at 20.34 yuan, latest price at 20.94 yuan, deviation rate of 2.93% [1] - Other notable stocks with lower deviation rates include: - Hongtaiyang: 2.77% increase, 5.00% turnover rate, annual line at 6.86 yuan, latest price at 7.04 yuan, deviation rate of 2.60% [1] - Xi'an Catering: 3.37% increase, 9.97% turnover rate, annual line at 8.77 yuan, latest price at 8.89 yuan, deviation rate of 1.37% [1] - Supor: 1.27% increase, 0.29% turnover rate, annual line at 51.39 yuan, latest price at 51.90 yuan, deviation rate of 1.00% [1]

Core Viewpoint - The A-share market shows a slight decline with the Shanghai Composite Index at 3677.06 points, down by 0.17%, while the total trading volume reached 1,893.89 billion yuan, indicating a mixed performance among stocks breaking through the annual line [1] Group 1: Market Performance - As of 13:59 today, the Shanghai Composite Index is at 3677.06 points, with a decrease of 0.17% [1] - The total trading volume of A-shares today is 1,893.89 billion yuan [1] Group 2: Stocks Breaking Through Annual Line - A total of 16 A-shares have surpassed the annual line today, with notable stocks including *ST Xin Yuan, *ST Hua Rong, and Meihao Medical, showing significant deviation rates of 5.64%, 4.40%, and 2.63% respectively [1] - Stocks with smaller deviation rates that have just crossed the annual line include Zhongke Ruankai, Tianwei Food, and Yongzhen Co., with minimal deviation percentages [1] Group 3: Deviation Rate Rankings - The top three stocks with the highest deviation rates are: - *ST Xin Yuan: 12.87% increase, 14.89% turnover rate, annual line at 6.06 yuan, latest price at 6.40 yuan, deviation rate of 5.64% [1] - *ST Hua Rong: 4.94% increase, 0.45% turnover rate, annual line at 7.12 yuan, latest price at 7.43 yuan, deviation rate of 4.40% [1] - Meihao Medical: 2.76% increase, 12.60% turnover rate, annual line at 20.34 yuan, latest price at 20.88 yuan, deviation rate of 2.63% [1]